KRT8 and lung adenocarcinoma: In conclusion, our exploratory study provides preliminary evidence that KRT8 expression may serve as a predictive biomarker for IRP in lung adenocarcinoma patients treated with immunotherapy, while the underlying biological mechanisms remain to be elucidated.